company background image
3692 logo

Hansoh Pharmaceutical Group SEHK:3692 주식 보고서

최종 가격

HK$18.52

시가총액

HK$109.9b

7D

8.4%

1Y

25.3%

업데이트

23 Nov, 2024

데이터

회사 재무 +

Hansoh Pharmaceutical Group Company Limited

SEHK:3692 주식 보고서

시가총액: HK$109.9b

3692 주식 개요

투자 지주회사인 한소제약그룹 유한회사는 중화인민공화국에서 의약품의 연구, 개발, 제조 및 판매에 종사하고 있습니다. 자세한 내용

3692 기본 분석
눈송이 점수
가치 평가3/6
미래 성장1/6
과거 실적5/6
재무 상태5/6
배당금2/6

Hansoh Pharmaceutical Group Company Limited 경쟁사

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Hansoh Pharmaceutical Group
과거 주가
현재 주가HK$18.52
52주 최고치HK$22.80
52주 최저치HK$11.18
베타0.65
11개월 변경-8.32%
3개월 변경 사항7.42%
1년 변경 사항25.30%
33년 변화9.33%
5년 변화-19.83%
IPO 이후 변화-5.03%

최근 뉴스 및 업데이트

Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Rather Sparingly

Nov 21
Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Rather Sparingly

Is Now The Time To Put Hansoh Pharmaceutical Group (HKG:3692) On Your Watchlist?

Nov 04
Is Now The Time To Put Hansoh Pharmaceutical Group (HKG:3692) On Your Watchlist?

Recent updates

Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Rather Sparingly

Nov 21
Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Rather Sparingly

Is Now The Time To Put Hansoh Pharmaceutical Group (HKG:3692) On Your Watchlist?

Nov 04
Is Now The Time To Put Hansoh Pharmaceutical Group (HKG:3692) On Your Watchlist?

Estimating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Aug 28
Estimating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Pinning Down Hansoh Pharmaceutical Group Company Limited's (HKG:3692) P/E Is Difficult Right Now

Aug 07
Pinning Down Hansoh Pharmaceutical Group Company Limited's (HKG:3692) P/E Is Difficult Right Now

If EPS Growth Is Important To You, Hansoh Pharmaceutical Group (HKG:3692) Presents An Opportunity

Jul 16
If EPS Growth Is Important To You, Hansoh Pharmaceutical Group (HKG:3692) Presents An Opportunity

Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt

Jun 24
Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt

Hansoh Pharmaceutical Group Company Limited's (HKG:3692) CEO Will Probably Find It Hard To See A Huge Raise This Year

Jun 06
Hansoh Pharmaceutical Group Company Limited's (HKG:3692) CEO Will Probably Find It Hard To See A Huge Raise This Year

Estimating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

May 23
Estimating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

May 01
Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?

Mar 28
Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?

There's Reason For Concern Over Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Massive 28% Price Jump

Mar 04
There's Reason For Concern Over Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Massive 28% Price Jump

An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 28% Undervalued

Feb 16
An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 28% Undervalued

Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly

Dec 08
Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly

Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Could Be 25% Below Their Intrinsic Value Estimate

Oct 12
Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Could Be 25% Below Their Intrinsic Value Estimate

Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's

Sep 14
Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's

These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well

Sep 09
These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well

Calculating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Jul 10
Calculating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well

Jun 11
These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well

Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Jan 23
Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet

Dec 01
Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet

Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 65% Above Its Share Price

Oct 19
Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 65% Above Its Share Price

Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt

Aug 28
Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt

An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 44% Undervalued

Jun 09
An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 44% Undervalued

Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing

May 19
Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing

Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?

Apr 22
Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?

An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 45% Undervalued

Feb 06
An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 45% Undervalued

주주 수익률

3692HK PharmaceuticalsHK 마켓
7D8.4%0.07%-0.6%
1Y25.3%-10.2%9.6%

수익률 대 산업: 3692 지난 1년 동안 -10.2 %를 반환한 Hong Kong Pharmaceuticals 산업을 초과했습니다.

수익률 대 시장: 3692 지난 1년 동안 9.6 %를 반환한 Hong Kong 시장을 초과했습니다.

가격 변동성

Is 3692's price volatile compared to industry and market?
3692 volatility
3692 Average Weekly Movement7.5%
Pharmaceuticals Industry Average Movement6.8%
Market Average Movement8.9%
10% most volatile stocks in HK Market19.2%
10% least volatile stocks in HK Market4.3%

안정적인 주가: 3692 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.

시간에 따른 변동성: 3692 의 주간 변동성( 7% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립직원CEO웹사이트
19959,099Huijuan Zhongwww.hspharm.com

투자 지주회사인 한소제약그룹 유한회사는 중화인민공화국에서 의약품의 연구, 개발, 제조 및 판매에 종사하고 있습니다. 항종양, 항감염, 중추신경계 질환, 종양학, 대사 및 자가면역 질환 등의 치료 분야에 제품을 공급하고 있습니다. 주요 제품으로는 아메일, 한소신푸, 풀라이일, 제페이, 신타이, 신메이, 가이눠, 헝무, 메일링다, 헝센, 신위, 생루오라이, 풀라이메이, 퓰라이탄, 탄넝, 아메이닝, 오울란, 루이보테, 풀라이디, 풀라이이, 푸루안 정제가 있습니다.

Hansoh Pharmaceutical Group Company Limited 기본 사항 요약

Hansoh Pharmaceutical Group 의 수익과 매출은 시가총액과 어떻게 비교하나요?
3692 기본 통계
시가총액HK$109.90b
수익(TTM)HK$5.06b
수익(TTM)HK$13.00b

21.7x

P/E 비율

8.5x

P/S 비율

3692 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
3692 손익 계산서(TTM)
수익CN¥12.10b
수익 비용CN¥1.09b
총 이익CN¥11.01b
기타 비용CN¥6.30b
수익CN¥4.71b

최근 보고된 수익

Jun 30, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)0.79
총 마진91.01%
순이익 마진38.97%
부채/자본 비율0.1%

3692 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

배당금

2.1%

현재 배당 수익률

40%

지급 비율